Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Academic History

Nicolaus Kröger, MD, is the Medical Director of the Department of Stem Cell Transplantation at the University Medical Center Hamburg-Eppendorf, Hamburg, Germany, as well as a Professor of Medicine at the University of Hamburg.

After obtaining an MD from the University of Hamburg, Dr Kröger pursued specialized training in Hematology at The University of Texas MD Anderson Cancer Center, Houston, TX, achieving Board certification in Hematology and Medical Oncology. Following residency in the Department of Hematology and Oncology, he assumed the role of Senior Consultant in Bone Marrow Transplantation at the University of Hamburg.

Dr Kröger has chaired and been a President of the Scientific Council of the European Society for Blood and Marrow Transplantation (EBMT) and has been Chairman of the Chronic Malignancies Working Party (CMWP). He has also been a Board Member of the German Stem Cell Transplantation Group.

Speaking on stem cell transplantation, GvHD, and CAR-T therapy

Dr Kröger’s research focuses on clinical hematopoietic stem cell transplantation (HSCT), the identification and management of measurable residual disease (MRD), and the comparison of outcomes of CAR-T therapy versus HSCT. His work also explores the influence of NK-cell allo-reactivity, optimizing outcomes with HLA-mismatched donors, and strategies for preventing and treating chronic graft-versus-host disease (GvHD). He places a particular emphasis on the development of conditioning regimens, specifically in the contexts of multiple myeloma, myelodysplastic syndromes (MDS), and myelofibrosis (MF).